In the short term, Eli Lilly and Novo Nordisk will continue to dominate due to strong branding and doctor trust. But in the medium to long term, expect Indian pharma to emerge as a major competitive ...

This article was reviewed by Lynn Marie Morski, MD, JD. Ozempic Stomach Paralysis: Risks & Treatments Key takeaways: Stomach ...

ROANOKE, Va. (WDBJ) - There’s mounting evidence that popular drugs prescribed for diabetes management and weight loss — ...

Sustaining healthy weight loss is about so much more than cutting calories or injecting drugs, as many GLP-1 users are ...

More work needs to be done to tease out the mechanisms by which GLP-1 RAs lower the risk of MACE, researchers say.

GLP-1 drugs like Mounjaro, which were created to help type 2 diabetes patients and sometimes manage weight loss, actually ...

CHICAGO -- A series of large, real-world analyses supported benefit of GLP-1 receptor agonists in cardiopulmonary indications for patients with type 2 diabetes, researchers reported at the CHEST ...

By Laura Howard In 2024, Black or African-American adults were 28% more likely to be obese than adults of the total ...

Around 30% of GLP-1 users surveyed consumed fewer sweet baked snacks, sweet snacks like candy, packaged cookies and ...

This week’s roundup covers the FDA greenlighting next-gen proteins, General Mills targeting 55+ and GLP-1 consumers and ...

Researchers at Virginia Polytechnic Institute and State University took 20 people living with obesity (half on GLP-1s like ...

See, LLY stock warrants your attention. Why? Because it offers monopoly-like high margins at a discounted price.